Ensitrelvir: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ensitrelvir. Educational only — not medical advice.
Labeled uses
XOCOVA is indicated for post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) in adults and adolescents 12 years of age and older following contact with an individual who has COVID-19.
Source: FDA labeling via NIH DailyMed (set 526acf60…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.